Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids

Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids

One major challenge associated with lung cancer organoids (LCOs) is their predominant derivation from surgical specimens of patients with early-stage lung cancer. However, patients with advanced lung cancer, who are in need of chemotherapy, often cannot undergo surgery. Therefore, there is an urgent...

Full description

Bibliographic Details
Main Authors: Dongil Park, Dahye Lee, Yoonjoo Kim, Yeonhee Park, Yeon-Jae Lee, Jeong Eun Lee, Min-Kyung Yeo, Min-Woong Kang, Yooyoung Chong, Sung Joon Han, Jinwook Choi, Jong-Eun Park, Yongjun Koh, Jaehyeok Lee, YongKeun Park, Ryul Kim, Jeong Seok Lee, Jimin Choi, Sang-Hyun Lee, Bosung Ku, Da Hyun Kang, Chaeuk Chung
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cells
Subjects:
cryobiopsy
lung cancer
organoid
high cancer cell purity
three-dimensional holotomography
drug screening
Online Access:https://www.mdpi.com/2073-4409/12/14/1854

Internet

https://www.mdpi.com/2073-4409/12/14/1854

Similar Items